Created from the personal and professional experiences of former executive government regulators, public health officials and policy makers, The Licentiam Team is simplifying and streamlining the outdated and disconnected health regulatory environment.
Mark Vargas, President
Mark Vargas is President of Licentiam, a medical licensing service and innovative technology company. He is a trusted adviser and close confidante to high profile political and business leaders. His work as a tech entrepreneur and opinion writer have been featured in the Chicago Sun-Times, Chicago Tribune, Daily Herald, Huffington Post and Fox News.
Prior to Licentiam, Mr. Vargas was a Principal at a government and public affairs consulting firm in Washington, D.C. where he advised both individuals and organizations on issue advocacy and message development. He also served as Vice President of a boutique health care consulting firm with a focus in government affairs and testified frequently as an expert witness before the District of Columbia Committee on Health and Human Services.
From 2007-2010, Mr. Vargas served as a civilian adviser in Iraq within the Office of the Secretary of Defense. In 2009 he was awarded the Secretary of Defense Global War on Terrorism Civilian Service Medal, and in 2010 he was awarded the Under Secretary of Defense Financial Management Team Award for Financial Management Innovations in a Combat Zone, becoming the Pentagon’s first recipient of such an award. His civilian service at the Defense Department included 14 trips to Baghdad and expanded across two presidential administrations.
Mr. Vargas is a regular panelist and guest speaker on issues related to entrepreneurship, technology and innovation, political affairs and foreign policy. A dedicated writer, Mr. Vargas is also contributor for the Washington Examiner..
Dr. Jason Reed, Co-founder & Partner
Dr. Reed is a clinically trained pharmacist with practice experience in both acute and critical care settings. He has served his home state of NJ and his country as a public health pharmacist on the NJ-1 Disaster Medical Assistance Team (DMAT), where he received extensive training and experience in disaster medicine and management of public health crises. In this capacity, Dr. Reed honed his administrative and logistical skills through multiple deployments including the federal response to Hurricanes Katrina and Rita, where he was tasked with helping to re-establish medical infrastructure immediately following the storms through field based operations and coordination of medication and vaccine distribution and rationing efforts.
Dr. Reed's leadership experience includes oversight of pharmacy operations in oncology at one of the world's largest translational and clinical research facilities. In this role, he was tasked with ensuring compliance with Code of Federal Regulations in support of investigational drug therapy protocols as well as readiness for audit by local, state, federal, and international regulatory bodies. Toward this end, Dr. Reed has led enterprise-wide initiatives for development and implementation of technology solutions to enhance data tracking, management, and reporting capabilities. These innovative regulatory technology solutions have been adapted and implemented nationally at premier academic medical institutions and Comprehensive Cancer Care centers, thereby promoting standardization of compliance strategies and pharmacy best practices in clinical research.
Dr. Reed has served as a consultant to the pharmaceutical industry and academia on the design and conduct of clinical research protocols, as well as on drug development and post-approval strategies when bringing drugs to market. He received his BS in pharmacy from Rutgers University graduating as class Valedictorian, and his PharmD at the University of Florida graduating cum laude.
Dr. Rikin Mehta, Adviser
Dr. Rikin Mehta is an executive health professional,
pharmacist and attorney with deep experience in State and Federal health and
pharmaceutical regulatory practice.
Prior to his current role, Dr. Mehta was the Head of
Regulatory Policy for Pfizer Consumer Health where he worked to advance
industry and FDA policy discussions on increasing access to drugs to mitigate
the undertreatment of diseases and conditions. He briefly served as the Pfizer
representative on the Board of Directors for the Council for Responsible
Nutrition. Prior to industry, Dr. Mehta was politically appointed as the
executive public health official for the DC Department of Health where he
directed the regulatory affairs department charged with protecting and
enforcing the District’s public health laws, including oversight for all
licensing matters. Prior to DCHealth, Dr. Mehta served as the Deputy Director
for the Division of Medical Policy Programs with the Office of Medical Policy
at the US Food and Drug Administration. Dr. Mehta started his FDA career in
CDER, Office of Compliance (OC), where he worked on the Agency’s unapproved and
counterfeit drugs initiative, and supply chain security policies.
Dr. Mehta holds a B.S., Pharm.D., J.D. and LL.M in global
health law, and is an adjunct professor of law at Georgetown University Law
Center where he teaches courses in health and drug laws and regulations.